For the quarter ending 2026-03-31, ZBH made $2,086,700K in revenue. $238,100K in net income. Net profit margin of 11.41%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 2,086,700 | 2,243,700 | 2,001,400 | 2,077,300 |
| Cost of products sold, excluding intangible asset amortization | 576,200 | 792,400 | 559,300 | 592,200 |
| Intangible asset amortization | 162,100 | 177,800 | 176,500 | 160,600 |
| Research and development | 103,400 | 118,700 | 115,900 | 113,300 |
| Selling, general and administrative | 849,900 | 872,200 | 811,400 | 814,800 |
| Restructuring and other cost reduction initiatives | 6,300 | 106,300 | 21,400 | 17,500 |
| Acquisition, integration, divestiture and related | 15,600 | 21,800 | -34,400 | 78,900 |
| Operating expenses | 1,713,500 | 2,089,200 | 1,650,100 | 1,777,300 |
| Operating profit | 373,200 | 154,500 | 351,300 | 300,000 |
| Other (expense) income, net | -3,000 | 15,400 | 3,300 | 3,900 |
| Interest expense, net | -68,800 | -71,900 | -75,400 | -79,300 |
| Earnings before income taxes | 301,300 | 98,000 | 279,200 | 224,600 |
| Provision for income taxes | 63,000 | -40,000 | 48,000 | 71,200 |
| Net earnings | 238,300 | 137,900 | 231,200 | 153,400 |
| Less net earnings attributable to noncontrolling interest | 200 | -1,600 | 300 | 600 |
| Net earnings of zimmer biomet holdings, inc | 238,100 | 139,400 | 230,900 | 152,800 |
| Basic EPS | 1.22 | 0.707 | 1.17 | 0.77 |
| Diluted EPS | 1.22 | 0.704 | 1.16 | 0.77 |
| Basic Average Shares | 195,000,000 | 197,100,000 | 198,100,000 | 197,900,000 |
| Diluted Average Shares | 195,800,000 | 198,000,000 | 198,800,000 | 198,300,000 |
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
ZIMMER BIOMET HOLDINGS, INC. (ZBH)